CDKN2A and precursor B-cell acute lymphoblastic leukemia: The finding that TP53 is ubiquitously perturbed in low-hypodiploid B-ALL suggests that mutations in an additional member of the TP53/RB1 pathway (either RB1 or CDKN2A/B) would be sufficient to deregulate cell proliferation in these cases.